Received: 3 May 2021
Accepted: 23 September 2021
First Online: 12 October 2021
: All animal protocols described in this study were approved by the Institutional Animal Care and Use Committee (IACUC: 2018120202) at The Kanion Parmaceutical (Lianyungang, Jiangsu,China).
: We would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication.
: The authors declare no competing interests.